Tonix Pharmaceuticals Holding (TNXP) Current Assets: 2023-2025
Historic Current Assets for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $208.1 million.
- Tonix Pharmaceuticals Holding's Current Assets rose 311.67% to $208.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.1 million, marking a year-over-year increase of 311.67%. This contributed to the annual value of $119.0 million for FY2024, which is 149.12% up from last year.
- Latest data reveals that Tonix Pharmaceuticals Holding reported Current Assets of $208.1 million as of Q3 2025, which was up 44.96% from $143.5 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's Current Assets' 5-year high stood at $208.1 million during Q3 2025, with a 5-year trough of $25.3 million in Q2 2024.
- Moreover, its 3-year median value for Current Assets was $51.3 million (2023), whereas its average is $85.5 million.
- Its Current Assets has fluctuated over the past 5 years, first tumbled by 64.05% in 2024, then surged by 467.62% in 2025.
- Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Current Assets stood at $47.8 million in 2023, then skyrocketed by 149.12% to $119.0 million in 2024, then surged by 311.67% to $208.1 million in 2025.
- Its Current Assets was $208.1 million in Q3 2025, compared to $143.5 million in Q2 2025 and $149.6 million in Q1 2025.